Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The systemic treatment of recurrent ovarian cancer revisited.
Baert T, Ferrero A, Sehouli J, O'Donnell DM, González-Martín A, Joly F, van der Velden J, Blecharz P, Tan DSP, Querleu D, Colombo N, du Bois A, Ledermann JA. Baert T, et al. Among authors: colombo n. Ann Oncol. 2021 Jun;32(6):710-725. doi: 10.1016/j.annonc.2021.02.015. Epub 2021 Mar 3. Ann Oncol. 2021. PMID: 33675937 Free article. Review.
Overexpression of p185 is not related to erbB2 amplification in ovarian cancer.
Morali F, Cattabeni M, Tagliabue E, Campiglio M, Menard S, Marzola M, Lucchini V, Colombo N, Mangioni C, Redaelli L, et al. Morali F, et al. Among authors: colombo n. Ann Oncol. 1993 Nov;4(9):775-9. doi: 10.1093/oxfordjournals.annonc.a058663. Ann Oncol. 1993. PMID: 7904177 Free article.
Advanced ovarian cancer. Dose intensity.
Ozols RF, Thigpen JT, Dauplat J, Colombo N, Piccart MJ, Bertelsen K, Levin L, Lund B. Ozols RF, et al. Among authors: colombo n. Ann Oncol. 1993;4 Suppl 4:49-56. Ann Oncol. 1993. PMID: 8312201 Review.
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica.
Bolis G, Colombo N, Pecorelli S, Torri V, Marsoni S, Bonazzi C, Chiari S, Favalli G, Mangili G, Presti M, et al. Bolis G, et al. Among authors: colombo n. Ann Oncol. 1995 Nov;6(9):887-93. doi: 10.1093/oxfordjournals.annonc.a059355. Ann Oncol. 1995. PMID: 8624291 Free article. Clinical Trial.
Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study.
Vermorken JB, Zanetta G, De Oliveira CF, van der Burg ME, Lacave AJ, Teodorovic I, Boes GH, Colombo N. Vermorken JB, et al. Among authors: colombo n. Ann Oncol. 2001 Jul;12(7):967-74. doi: 10.1023/a:1011165115426. Ann Oncol. 2001. PMID: 11521804 Free article. Clinical Trial.
Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens.
Cantù MG, Buda A, Parma G, Rossi R, Floriani I, Bonazzi C, Dell'Anna T, Torri V, Colombo N. Cantù MG, et al. Among authors: colombo n. J Clin Oncol. 2002 Mar 1;20(5):1232-7. doi: 10.1200/JCO.2002.20.5.1232. J Clin Oncol. 2002. PMID: 11870165 Clinical Trial.
577 results